Top Story New UK Prime Minister Burnham Promises Hope and Change. The Hurdles Are High. The New York Times · world 10m ago Read
2 Reason(s) to Buy Warren Buffett's Favorite Artificial Intelligence (AI) Stock and Never Sell NASDAQ · markets 55m ago Read
‘Too Rare to Care’? A New Center for Rare Diseases Hopes to Change That The New York Times · health 56m ago Read
Why States Are Making It Harder to Save Money With Solar Panels The New York Times · business 57m ago Read
Hot, Uncomfortable, Matchless: Opera Pilgrims Can’t Quit Bayreuth The New York Times · arts 58m ago Read
The Ordeal of a 42-Day Hantavirus Quarantine: ‘I Felt Like a Prisoner’ The New York Times · health 59m ago Read
Cristo Fernandez Talks Returning to Pro Soccer After “Ted Lasso” The New York Times · arts 59m ago Read
Prediction: Broadcom Stock Will Be Worth More Than Apple and Microsoft 10 Years From Now NASDAQ · markets 1h ago Read
Kevin Warsh Made His First Big Move as Fed Chair, and the Bond Market Has Taken Action -- but Most Investors Missed It NASDAQ · markets 1h ago Read
UK’s New Prime Minister Burnham Orders Cut in Taxes on Electricity The New York Times · world 1h ago Read
If You'd Invested $10,000 in Micron After Its IPO, Here's How Much You Would Have Now. NASDAQ · markets 1h ago Read
Australian Woman Gives Birth to ‘Miracle’ Identical Quadruplets The New York Times · world 2h ago Read
Kevin Warsh's Inflation Testimony Came as Traders Priced an 86% Chance of a Fed Rate Hold NASDAQ · markets 2h ago Read
RTX's Pratt & Whitney Canada Signs 5-Yr Maintenance Deal With Ireland's Emerald Airlines NASDAQ · markets 3h ago Read
Palantir and Sandisk Both Posted Blowout Earnings in 2026. The Stock Market Rewarded Only One of Them the Same Day. Here's the Difference. NASDAQ · markets 3h ago Read
Swatch Group H1 Attributable Profit Rises On Sales Growth; Sees Strong Sales, Profit In H2 NASDAQ · markets 3h ago Read
Marvell Technology: The Stock Is Down 39% From Its High. Time to Buy the Dip? (NASDAQ: MRVL) NASDAQ · markets 3h ago Read
Telix Pharmaceuticals Q2 Revenue Climbs Boosted By Precision Medicine Business NASDAQ · markets 4h ago Read
Barclays US Consumer Bank Issues Samsung Galaxy Credit Card On Visa Network NASDAQ · markets 4h ago Read
Cardinal Health To Buy AdaptHealth's Diabetes Unit, Strive Medical For $360 Mln Total NASDAQ · markets 5h ago Read
Elon Musk's Tesla Delivered 480,126 Vehicles in Its Best Quarter in 2 Years NASDAQ · markets 5h ago Read
Two months before Russian parliamentary elections, antiwar voices still struggle for traction Le Monde · international 6h ago Read
US launches new strikes against Iran after Trump warns country will pay for deaths of American soldiers Le Monde · international 6h ago Read
A Ransomware Attack Just Halted Coca-Cola's Fairlife Production and Knocked the Stock Down 4%. Should Dividend Investors Care? NASDAQ · markets 8h ago Read
Spain stars celebrate with adoring fans at World Cup parade of around two million in Madrid Le Monde · international 8h ago Read
Meta Stock's Rebound Made Mark Zuckerberg the World's Fifth-Richest Person at $222 Billion NASDAQ · markets 8h ago Read
Climate change: Why the ECB refuses to create a lower interest rate for green investments Le Monde · international 8h ago Read
What This Evolv Insider Sale Signals to Long-Term Investors as Revenue Jumped 45% NASDAQ · markets 8h ago Read
Burnham enters Downing Street and appoints former defense minister John Healey as chancellor of the Exchequer Le Monde · international 8h ago Read
Daniel Ortega, President of Nicaragua, Says He Plans to Abolish Elections The New York Times · world 9h ago Read
Corcept's CFO Set His Selling Plan the Month the Stock Fell 50% — Here's What Investors Should Know NASDAQ · markets 9h ago Read
A Corcept Director Holds 1.5 Million Shares Through a 50% Crash and Rebound NASDAQ · markets 9h ago Read
Netflix Has Plummeted Over the Past Year and Just Dropped Again on Earnings. At 22 Times Profits, Is It a Buy? NASDAQ · markets 9h ago Read
Nebius Stock Fell 40% From Its All-Time-High. Is This AI Stock Finally a Buy? NASDAQ · markets 10h ago Read
What This MannKind Filing Reveals About Three Years of Underperformance NASDAQ · markets 10h ago Read
What This MannKind Director Sale Signals With $32.7 Million in Quarterly Royalties Revenue Potentially at Risk NASDAQ · markets 10h ago Read
In southern Lebanon hospital, caregivers strive to overcome traumas of war Le Monde · international 10h ago Read
Why This MannKind Insider Stock Sale Matters Less Than a 9% Royalty at Risk NASDAQ · markets 10h ago Read
